Related Experiment Video
Updated: Jun 27, 2026

Bacteriophage Removal from Infected Salmonella Cultures
Published on: June 28, 2024
Morphological and genetic analysis of three bacteriophages of Serratia marcescens isolated from environmental water
Kenshi Matsushita1, Jumpei Uchiyama, Shin-ichiro Kato
1Department of Pediatrics, Kochi Medical School, Nankoku, Kochi, Japan. matuzaki@kochi-u.ac.jp
Abstract:
Increases in multidrug-resistant strains of Serratia marcescens are of great concern in pediatrics, especially in neonatal intensive care units. In the search for bacteriophages to control infectious diseases caused by multidrug-resistant S. marcescens, three phages (KSP20, KSP90, and KSP100) were isolated from environmental water and were characterized morphologically and genetically. KSP20 and KSP90 belonged to morphotype A1 of the family Myoviridae, and KSP100 belonged to morphotype C3 of the family Podoviridae. Analysis of the DNA region coding virion proteins, together with their morphological features, indicated that KSP20, KSP90, and KSP100 were related to the P2-like phage (temperate), T4-type phage (virulent), and phiEco32 phage (virulent), respectively. Based on amino acid sequences of the major capsid protein, KSP90 formed a new branch with a Stenotrophomonas maltophilia phage, Smp14, in the T4-type phage phylogeny. Both Smp14 and phiEco32 have been reported as potential therapeutic phages. These results suggest that KSP90 and KSP100 may be candidate therapeutic phages to control S. marcescens infection.
Insights
Three novel bacteriophages (KSP90, KSP100) show potential as therapeutic agents against multidrug-resistant Serratia marcescens infections, particularly in neonatal intensive care units. Further research is warranted to explore their efficacy in clinical settings.
Area of Science:
- Microbiology
- Virology
- Infectious Diseases
Background:
- Multidrug-resistant Serratia marcescens poses a significant threat in pediatric healthcare, especially in neonatal intensive care units.
- The rise of antibiotic resistance necessitates alternative strategies for controlling bacterial infections.
Purpose of the Study:
- To isolate and characterize bacteriophages with potential to combat multidrug-resistant Serratia marcescens.
- To evaluate candidate phages for their therapeutic potential against S. marcescens infections.
Main Methods:
- Isolation of bacteriophages from environmental water sources.
- Morphological characterization using electron microscopy.
- Genetic analysis including DNA sequencing and phylogenetic studies of virion proteins.
Main Results:
- Three bacteriophages, KSP20, KSP90, and KSP100, were isolated and characterized.
- KSP20 and KSP90 are morphotype A1 (Myoviridae), and KSP100 is morphotype C3 (Podoviridae).
- Phylogenetic analysis suggests KSP90 and KSP100 are related to known therapeutic phage groups, indicating their potential as antimicrobial agents.
Conclusions:
- Bacteriophages KSP90 and KSP100 demonstrate promise as candidate therapeutic agents against multidrug-resistant Serratia marcescens.
- These findings contribute to the development of phage therapy as an alternative to antibiotics for challenging bacterial infections.
Related Concept Videos
DNA Bacteriophages
Bacteriophages of the Human Virome
Bacterial Phylum Bacteroidota
Modern Molecular Taxonomy
Methods of Classification and Identification
Lytic Cycle of Bacteriophages

